ANALISIS SENYAWA FITOSTEROL Cymbopogon citratus dan Curcuma longa SEBAGAI ANTIALZHEIMER

  • Yohanes Bare
Keywords: acetylcholintransferase, alzheimer, Curcuma longa Cymbopogon citratus

Abstract

Background: Alzheimer is a disease with decreased episodic memory function and cognitive function. The
treatment system is carried out by inhibiting the performance of genes that have an Alzheimer's stimulus function.
Alzheimer sufferers have a component that functions as a cholin stimulator and Acetyl CoA is
Acetylcholintransferase. Treatment is done by inhibiting Acetylcholintransferase with Cymbopogon citratus and
Curcuma longa. The purpose of this study was to analyze the potential phytoserol content of Cymbopogon
citratus and Curcuma longa as anti-Alzheimer
Methods: The method used is the in-silico study approach. Protein Acetylcholintransferase (2fy3) was obtained
from Protein Data Bank (PDB). The three-dimensional structure of phytosterol compounds identified in
Cymbopogon citratus and Curcuma longa were downloaded from the PubChem database. Proteins and bioactive
compounds were prepared sequentially using the Discovery studio ver 19.0.0 and the PyRX 0.8 program.
Proteins and compounds were interacted with the PyRX 0.8 program and analyzed using the Discovery Studio
ver.21.1.0 software
Results: The results showed that the phytoserol content of Cymbopogon citratus and Curcuma longa (1,8
Cineole, 3,7-dimethyl-1,3,6-octatriene, Champene, Decanal Selina-6-en-4-ol, Zingiberene) inhibited the active
side of acetylcholinesterase by inhibiting acetylcholinesterase bind amino acid residues through essential oils.
This inhibition directly stops the hydrolysis process of acetylcholine into cholin and acetyl CoA so that it can
prevent damage to brain cells.
Conclusion: The phytoserol content of Cymbopogon citratus and Curcuma longa is predicted to have potential
as anti-Alzheimer through inhibition of Acetylcholintransferase

Downloads

Download data is not yet available.

References

DAFTAR PUSTAKA
Bare, Y., Helvina, M., Krisnamurti, G. C., & S, M. (2020). The Potential Role of 6-gingerol and 6-shogaol as ACE Inhibitors in Silico Study. Biogenesis: Jurnal Ilmiah Biologi, 8(2), 210. https://doi.org/10.24252/bio.v8i2.15704
Bare, Y., Kuki, A. D., Rophi, A. H., & Candrakirana, G. (2019). Prediksi Asam Kuinat Sebagai Anti-Inflamasi Terhadap COX-2 Secara Virtual Virtual Prediction of Quinic Acid As Anti-Inflammation of COX-2. Biota: Jurnal Ilmu-Ilmu Hayati, 4(3), 124–129. https://doi.org/10.24002/biota.v4i3.2516
Bare, Y., S, M., Tiring, S. S. N. D., Sari, D. R. T., & Maulidi, A. (2020). Virtual
Yohanes Bare. ANALISIS SENYAWA FITOSTEROL…158
Biopendix, Volume 7, Nomor 2, Maret 2021, hlm. 153-159
Screening: Prediksi potensi 8-shogaol terhadap c-Jun N-Terminal Kinase (JNK). Jurnal Penelitian Dan Pengkajian Ilmu Pendidikan: E-Saintika, 4(1), 1–6. https://doi.org/10.36312/e-saintika.v4i1.157
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013). Acetylcholinesterase Inhibitors: Pharmacology and Toxicology. Current Neuropharmacology, 11(3), 315–335. https://doi.org/10.2174/1570159X11311030006
de Wilde, M. C., Vellas, B., Girault, E., Yavuz, A. C., & Sijben, J. W. (2017). Lower brain and blood nutrient status in Alzheimer’s disease: Results from meta-analyses. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 3(3), 416–431.
Gemiralda, R. M., Marlaokta, M., & Marlaokta, M. (2019). Efek Neuroprotektor Kunyit pada Pasien Alzheimer. Jurnal Ilmu Keperawatan Jiwa, 2(3), 171. https://doi.org/10.32584/jikj.v2i3.431
Grossberg, G. T. (2003). Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease: Current Therapeutic Research, 64(4), 216–235. https://doi.org/10.1016/S0011-393X(03)00059-6
Robertson, S. S. (2016). Problem Solving: Perspectives from Cognition and Neuroscience. PA: Psychology Press.
Saify, Z. S., & Sultana, N. (2014). Chapter 7—Role of Acetylcholinesterase Inhibitors and Alzheimer Disease. In Atta-ur-Rahman & M. I. Choudhary (Eds.), Drug Design and Discovery in Alzheimer’s Disease (pp. 387–425). Elsevier. https://doi.org/10.1016/B978-0-12-803959-5.50007-6
Satish, S. (2013). Investigation on Essential oil of Cymbopogon citratus in Treatment of Alzheimer’s disease. Essential Oil of Cymbopogon Citratus Might Prove to Be a Useful Memory Restorative Agent in the Treatment of Dementia Seen in Elderly, 01(011), 17–25.
Schröter, D., Neugart, S., Schreiner, M., Grune, T., Rohn, S., & Ott, C. (2019). Amaranth’s 2-Caffeoylisocitric Acid—An Anti-Inflammatory Caffeic Acid Derivative That Impairs NF-κB Signaling in LPS-Challenged RAW 264.7 Macrophages. Nutrients, 11(3), 571. https://doi.org/10.3390/nu11030571
Silva, M. V. F., Loures, C. de M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. das G. (2019). Alzheimer’s disease: Risk factors and potentially protective measures. Journal of Biomedical Science, 26(1), 33. https://doi.org/10.1186/s12929-019-0524-y
Weller, J., & Budson, A. (2018). Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Research, 7, 1161. https://doi.org/10.12688/f1000research.14506.1
Zhou, W., Yan, H., & Hao, Q. (2012). Analysis of surface structures of hydrogen bonding in protein–ligand interactions using the alpha shape model. Chemical Physics Letters, 545, 125–131. https://doi.org/10.1016/j.cplett.2012.07.016
Published
2021-03-22
How to Cite
BareY. (2021). ANALISIS SENYAWA FITOSTEROL Cymbopogon citratus dan Curcuma longa SEBAGAI ANTIALZHEIMER. BIOPENDIX: Jurnal Biologi, Pendidikan Dan Terapan, 7(2), 153-159. https://doi.org/10.30598/biopendixvol7issue2page153-159